Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,174 | -4,203 | -3,151 | -2,547 | -2,063 |
| Net Acquisitions | 996 | -821 | -103,145 | N/A | N/A |
| Purchase Of Investment | -966 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -65,917 | -14,814 | -10,445 | N/A | -41 |
| Other Investing Activity | -25,443 | -30,976 | -8,803 | 0 | 0 |
| Investing Cash Flow | $-95,504 | $-50,814 | $-125,544 | $-2,547 | $-2,104 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,776 | 8,802 | 41,685 | N/A | N/A |
| Debt Repayment | -59,682 | -6,394 | -1,084 | -2,315 | -5,057 |
| Common Stock Issued | 118,596 | 18,147 | 89,577 | N/A | 1,467 |
| Common Stock Repurchased | -4,581 | -669 | -3,995 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -4,521 |
| Other Financing Activity | 0 | 0 | 0 | -2,881 | -6,556 |
| Financing Cash Flow | $115,109 | $19,886 | $126,183 | $-5,196 | $-14,667 |
| Exchange Rate Effect | 2,432 | -226 | 1,048 | 145 | -1,217 |
| Beginning Cash Position | 15,110 | 20,128 | 11,596 | 5,807 | 19,709 |
| End Cash Position | 59,201 | 14,813 | 18,938 | 11,596 | 5,807 |
| Net Cash Flow | $42,025 | $-4,792 | $7,484 | $5,644 | $-12,685 |
| Free Cash Flow | |||||
| Capital Expenditure | -83,603 | -35,296 | -21,059 | -2,547 | -2,104 |
| Free Cash Flow | -83,603 | -35,296 | -21,059 | -2,547 | -2,104 |